Pierre Beaurang, Chief Business Officer at Nurix Therapeutics, Inc. (NRIX), sold 7,500 shares at $23.88 ($179K) on 2021-07-12, disclosed to the SEC on 2021-07-12.
Open-market sale of $179k NRIX by Chief Business Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $23.88 | 7,100 | $170K | 94.5% |
| 2 | $24.73 | 400 | $10K | 5.5% |
| Total | $23.93 avg | 7,500 | $179K | 100% |
| Filing → |
| NRIX | SELL | 2021-05-11 | $378K | — | Filing → |
| NRIX | SELL | 2021-04-13 | $394K | — | Filing → |
| NRIX | SELL | 2021-03-09 | $548K | — | Filing → |